Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-27 @ 4:24 AM
Study NCT ID:
NCT01136967
Status:
COMPLETED
Last Update Posted:
2019-11-13
First Post:
2010-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08
Start Date Type:
ACTUAL
Primary Completion Date:
2013-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-02
First Submit QC Date:
None
Study First Post Date:
2010-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-13
Results First Submit QC Date:
None
Results First Post Date:
2016-03-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-23
Last Update Post Date:
2019-11-13
Last Update Post Date Type:
ACTUAL